Authorities have released more details about what led up to a fire that destroyed the historic Lake House Inn supper club in ...

Construction began in 1968 for the two-stadium complex. Initially, architect Charles Deaton designed the stadiums to share a rolling roof; however, this idea never came to fruition. Starting off the ...

The Kansas City Chiefs have suffered through a disappointing 2025 NFL season, missing the playoffs and seeing superstar quarterback Patrick Mahomes go down with a torn ACL that could put the start of ...

Nov 18 (Reuters) - The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' (ARWR.O), opens new tab drug for a type of genetic disorder that causes extremely high levels of fat in the ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

The Kansas City Chiefs have been one of the NFL’s most dominant teams of the last decade, winning three Super Bowl championships and playing in seven straight AFC Championship games. And while the ...

The Jacob Lake Inn near Grand Canyon's North Rim is seeing up to 90% reservation cancellations following the 145,000-acre Dragon Bravo Fire earlier this year. The Inn's manager cited significant ...

Among the quiet pines above Lake Arrowhead, a battle is underway, one that will decide who calls the shots in the unincorporated community nestled in the San Bernardino Mountains. In 1915, property ...

Pasadena-based Arrowhead Pharmaceuticals Inc. has announced another major licensing deal with a pharma giant. This one is with Basel, Switzerland-based Novartis for $200 million in upfront payment and ...

Arrowhead, ranked No. 1 in High School on SI Wisconsin's Top 25, remains undefeated with a 3-0 overall record. The reigning Classic 8 Conference co-champion Warhawks have combined to outscore their ...

Novartis has been on a deal-making spree in 2025, including buyouts and licensing pacts, as it prepares for looming patent expirations on several blockbuster medicines. H.C. Wainwright analysts said ...

- Upon closing, Arrowhead will receive an upfront payment of $200 million - Novartis will receive an exclusive worldwide license to ARO-SNCA, Arrowhead’s preclinical stage siRNA therapy for the ...